General Motors, Magna, and Wipro Team Up to Develop Automotive Software Marketplace: ‘SDVerse’
SDVerse serves as a ‘matchmaking’ platform between buyers and sellers of embedded automotive software Focuses on matching automotive software buyers […]
MedMatrix Go-to-Market Pricing Announced for AI Product Suite Addressing US$726 Billion Market
VANCOUVER, British Columbia, March 05, 2024 (GLOBE NEWSWIRE) — MedBright AI Investments Inc. (the “Company” or “MedBright”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7) […]
Cartesian Therapeutics Announces New Employment Inducement Grant
GAITHERSBURG, Md., March 05, 2024 (GLOBE NEWSWIRE) — Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company developing […]
Safran Selects Gilat for Strategic, Multimillion-Dollar In-Flight Connectivity Program
PETAH TIKVA, Israel, March 05, 2024 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader […]
Arqit announces reseller agreement with Total Computers
LONDON, March 05, 2024 (GLOBE NEWSWIRE) — Arqit Quantum Inc. (Nasdaq: ARQQ, ARQQW) (Arqit), a leader in quantum-safe encryption, today […]
Nasdaq Outlines Strategy to Deliver Next Phase of Resilient and Scalable Growth
Highlights enhanced value-creation opportunity following strategic pivot to a platform business with a more scalable, recurring, and profitable revenue profile […]
First Watch Restaurant Group, Inc. Reports Strong 2023 Financial Results and Provides 2024 Outlook
Total revenues of $891.6 million, up 22.1% and System-wide sales of $1.1 billion, up 20.6% Same-restaurant sales growth of 7.6%* […]
Agios to Present at the Leerink Partners Global Biopharma Conference on March 12, 2024
CAMBRIDGE, Mass., March 05, 2024 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK […]
Axsome Therapeutics to Present at the Leerink Partners Global Biopharma Conference
NEW YORK, March 05, 2024 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel […]
ADMA Biologics to Participate in the Raymond James Institutional Investor Conference
RAMSEY, N.J. and BOCA RATON, Fla., March 05, 2024 (GLOBE NEWSWIRE) — ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the […]
